Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous Bicillin L-A for syphilis
ACTRN12625000210471Phase 2Not yet recruiting
- Sponsor
- The Kids Research Institute Australia
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of benzylpenicillin in syphilis, sponsored by The Kids Research Institute Australia. Primary endpoint: Safety and tolerability. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
benzylpenicillin
03
Conditions
syphilis
Beyond the preview
Go deeper on ACTRN12625000210471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625000210471.